Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD Patients

Trial Profile

Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD Patients

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 29 Dec 2016

At a glance

  • Drugs Quercetin (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Biomarker; Pharmacokinetics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Jul 2015 Planned End Date changed from 1 Dec 2014 to 1 Oct 2015 as reported by ClinicalTrials.gov record.
    • 24 Jul 2015 Planned primary completion date changed from 1 Oct 2014 to 1 Oct 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top